Sonnet BioTherapeutics is no longer just a cancer drug developer. Its $888 million merger will place it among the largest HYPE holders, blurring the lines between traditional finance and decentralized protocols in a high-stakes treasury experiment. According to a July…
Related Posts
XRP rally accelerates as price breaks above $3
XRP is surging this week, with its price climbing past the key $3 level as bullish momentum builds…
Zepz launches new digital wallet on Solana
Zepz, a digital remittances provider behind WorldRemit and Sendwave, has unveiled a new crypto wallet on Solana. Sendwave…
Hyperliquid whale holds $38M short against Bitcoin, but does it matter?
A Hyperliquid whale holds large short positions against Bitcoin and several altcoins. Does the position provide any signal…